Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

334
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
334
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

115
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
115
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

166
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
166
Actuarial Approach01:20

Actuarial Approach

69
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
69
Censoring Survival Data01:09

Censoring Survival Data

73
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
73
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

35
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
35

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Artificial intelligence-enabled plaque characterization from coronary computed tomography establishes basis of angina in women with nonobstructive atherosclerosis.

Communications medicine·2026
Same author

Paramagnetic Rim Lesions Are Associated With Trans-Synaptic Degeneration of the Visual Pathway in Multiple Sclerosis.

Annals of clinical and translational neurology·2026
Same author

Modified Skew Discrete Laplace Regression Models for Integer-Valued Data With Applications to Paired Samples.

Biometrical journal. Biometrische Zeitschrift·2025
Same author

The multivariate shared truncated normal frailty model with application to medical data.

Scientific reports·2025
Same author

A new proportional hazard model with applications to breastfeeding data.

Scientific reports·2025
Same author

Examining Explicit Stereotype Perceptions of Colorectal Cancer Screening and Diagnosis in the Hispanic Community.

Journal of cancer education : the official journal of the American Association for Cancer Education·2025
Same journal

When to Adjust for Multiple Testing: A Unifying Guiding Principle.

Biometrical journal. Biometrische Zeitschrift·2026
Same journal

Ensuring Quality in Preclinical Research: The Importance of Being Human.

Biometrical journal. Biometrische Zeitschrift·2026
Same journal

Addressing Cluster-Level Treatment Effect Heterogeneity in Sample Size Determination for Hierarchical 2 × 2 Factorial Designs.

Biometrical journal. Biometrische Zeitschrift·2026
Same journal

A Multiple Imputation Approach to Distinguish Curative From Life-Prolonging Effects in the Presence of Missing Covariates.

Biometrical journal. Biometrische Zeitschrift·2026
Same journal

Tests for Categorical Data Beyond Pearson: A Distance Covariance and Energy Distance Approach.

Biometrical journal. Biometrische Zeitschrift·2026
Same journal

Nonparametric Estimation of the Patient-Weighted While-Alive Estimand.

Biometrical journal. Biometrische Zeitschrift·2026
See all related articles

Related Experiment Video

Updated: Jun 17, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K

A New Mixture Model With Cure Rate Applied to Breast Cancer Data.

Diego I Gallardo1, Márcia Brandão2, Jeremias Leão2

  • 1Departamento de Estadística, Facultad de Ciencias, Universidad del Bío-Bío, Concepción, Chile.

Biometrical Journal. Biometrische Zeitschrift
|August 6, 2024
PubMed
Summary
This summary is machine-generated.

We developed a novel long-term survival model using a mixture of Poisson and Birnbaum-Saunders distributions for competing risks. This flexible model accurately estimates cure rates and outperforms traditional methods in breast cancer incidence data.

Keywords:
Birnbaum–Saundersbreast cancer datacompeting causescure rate modelexpectation–maximization algorithm

More Related Videos

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

239
Quantification of Breast Cancer Cell Invasiveness Using a Three-dimensional 3D Model
08:08

Quantification of Breast Cancer Cell Invasiveness Using a Three-dimensional 3D Model

Published on: June 11, 2014

15.8K

Related Experiment Videos

Last Updated: Jun 17, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.0K
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

239
Quantification of Breast Cancer Cell Invasiveness Using a Three-dimensional 3D Model
08:08

Quantification of Breast Cancer Cell Invasiveness Using a Three-dimensional 3D Model

Published on: June 11, 2014

15.8K

Area of Science:

  • Biostatistics
  • Survival Analysis
  • Statistical Modeling

Background:

  • Traditional survival models often struggle with complex scenarios involving multiple competing causes of failure.
  • Modeling the cure rate, which represents individuals unlikely to experience an event, is crucial in long-term studies.
  • Existing methods may not adequately capture the nuances of competing risks and covariate effects on cure rates.

Purpose of the Study:

  • To introduce a new flexible long-term survival model for analyzing data with competing risks.
  • To investigate the statistical properties and theoretical underpinnings of the proposed model.
  • To demonstrate the model's ability to directly incorporate covariates for modeling cure rates.

Main Methods:

  • A novel survival model is proposed, assuming competing causes follow a mixture of Poisson and Birnbaum-Saunders distributions.
  • Statistical properties, including the emergence of the promotion time model as a limiting case, are derived.
  • An Expectation-Maximization (EM) algorithm is developed for parameter estimation using maximum likelihood (ML).
  • Monte Carlo simulations are used to evaluate estimation performance and power of the likelihood ratio (LR) test.
  • The model is applied to a real-world breast cancer incidence dataset.

Main Results:

  • The proposed model allows for direct modeling of cure rates as a function of covariates.
  • Sufficient conditions for the consistency and asymptotic normality of ML estimators are established.
  • Simulation studies confirm the model's performance and the LR test's power compared to the promotion time model.
  • Application to breast cancer data shows superior model fitting compared to traditional approaches.

Conclusions:

  • The new survival model offers a flexible and powerful tool for analyzing long-term survival data with competing risks.
  • The model effectively incorporates covariates to estimate cure rates, providing valuable insights.
  • The proposed methodology demonstrates practical utility and potential for improved analysis in epidemiological and clinical research.